Life ScienceCompany
GlaxoSmithKline has acquired 30 companies, including 6 in the last 5 years. A total of 5 acquisitions came from private equity firms. It has also divested 23 assets.
GlaxoSmithKline’s largest acquisition to date was in 2000, when it acquired SmithKline Beecham for $75.7B. It’s largest disclosed sale occurred in 2013, when it sold Lucozade Ribena Suntory to Suntory Beverage & Food Limited for $2.1B. GlaxoSmithKline has acquired in 11 different US states, and 10 countries. The Company’s most targeted sectors include life science (80%) and healthcare services (7%).
Join Mergr and gain access to GlaxoSmithKline’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
M&A Summary
-
M&A Total Activity53
- M&A Buy Activity30
- M&A Sell Activity23
- Total Sectors Invested 5
- Total Countries Invested 10
- M&A Buy/Sell Connections 29
- M&A Advisors 9
Unlimited Searches
